GlassScriptPhysician profile
Philippe Lanauze
NPI 1134108145
$592.81
in general payments reported to CMS, 2019-2025
7 companies · $163 in 2025
The $163 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $123 · 2020: $56.66 · 2022: $125 · 2023: $105 · 2024: $19.16 · 2025: $163.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $288.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $287.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ge Healthcare | $163.16 | 2025 | |
| Cook Medical LLC | $125.06 | 2022 | |
| Sirtex Medical INC | $109.12 | 2020-2023 | Sir-Spheres Microspheres |
| Medical Device Business Services, INC. | $98.49 | 2019 | |
| Trisalus Life Sciences, INC. | $52.91 | 2023 | Trinav Infusion System |
| Ekos Corporation | $24.91 | 2019 | |
| Boston Scientific Corporation | $19.16 | 2024 | Embold Fibered |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Philippe Lanauze listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.